Recent investigations have progressively identified members of the sirtuin family, notably SIRT1 and SIRT2, as key regulators of multiple adaptive strategies used by tumor cells to avoid chemotherapy-induced lethal effects. The gene discussed is SIRT2; the disease is neoplasm.